Latest Breaking News On - Numab therapeutics - Page 1 : comparemela.com

Board Change | Company Announcement

Board Change | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Christophe chassagnolePeter sargentJames bellmanJim millenCompany nominated adviserCompany virtual tumourDirectors of the companyStrand hanson ltdMerck kgaParty transactionMerck kgaaChief scientific officerVirtual tumourNominated adviserStrand hansonHanson ltd

J&J buys Numab s lead atopic dermatitis bispecific for $1 25B

J&J buys Numab s lead atopic dermatitis bispecific for $1 25B
bioworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioworld.com Daily Mail and Mail on Sunday newspapers.

Yellow jersey therapeuticsNumab therapeuticsMultispecific antibody based therapeuticsCognate heterodimerization

Health: J&J acquires experimental skin disorder drug for $1 25 billion

Health: J&J acquires experimental skin disorder drug for $1 25 billion
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United statesNovo nordiskNumab therapeuticsShockwave medical

J&J to acquire Numab s Yellow Jersey Therapeutics in deal worth $1 25bn

J&J to acquire Numab s Yellow Jersey Therapeutics in deal worth $1 25bn
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

David leeDavid urechNumab therapeuticsYellow jersey therapeuticsProtagonist therapeutics

Johnson & Johnson s Drug Seltorexant Aces Late-Stage Depression Trial - Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson reported successful Phase 3 trial results for seltorexant, an investigational treatment for major depressive disorder with insomnia.

United statesJohnson johnsonjnjannouncedAmerican society of clinical psychopharmacologyAmerican societyClinical psychopharmacologyNumab therapeutics